MyLeukemiaTeam

Survival rates for MDS (myelodysplastic syndrome) vary quite a bit depending on your risk level. Here's a general breakdown:

- Very low-risk MDS: About a 3% chance of progressing to acute myeloid leukemia (AML) within five years
- Low-risk MDS: Average survival of around 5.3 years
- High-risk MDS: Average survival of Show Full Answer

Survival rates for MDS (myelodysplastic syndrome) vary quite a bit depending on your risk level. Here's a general breakdown:

- Very low-risk MDS: About a 3% chance of progressing to acute myeloid leukemia (AML) within five years
- Low-risk MDS: Average survival of around 5.3 years
- High-risk MDS: Average survival of around 1.6 years
- Very high-risk MDS: Up to an 84% chance of developing AML within five years Risk is measured using the International Prognostic Scoring System (IPSS), which looks at three key factors:

- Gene changes in your cancer cells
- Cytopenia (low blood cell counts)
- Blast count (the number of immature cells in your blood or bone marrow)

The higher your IPSS score, the higher your risk level. It's really important to remember that these are averages based on large groups of people — they don't predict what will happen to any one individual. Your doctor can give you a much clearer picture based on your specific situation, subtype, and risk score. Don't hesitate to ask them about what these numbers mean for you personally.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Treatment Advances for MDS

What Is Myelodysplastic Syndrome (MDS)?